Form 4 for MDT Medtronic
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-01 · accession 0001127602-22-003243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-03 | 2022-02-01 | MDT | Fong Ivan K | EVP GC, SECR | A - Grant | $0.00 | +30.4K | 30.4K | New | $0 |
| DM | 2022-02-03 | 2022-02-01 | MDT | Fong Ivan K | EVP GC, SECR | A - Grant | $87.23 | +233.2K | 15.6K | New | +$20.34M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-02-01 | A | A | 6,237 | $0.00 | 6,237 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-02-01 | A | A | 24,134 | $0.00 | 30,371 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-01 | A | A | 50,476 | $103.59 | 50,476 | D | $103.59 · 2022-08-02 to 2031-08-02 | 50,476 Ordinary Shares | (F3) These options become exercisable at the rate of 25% of the shares granted per year beginning on the date noted. |
| 4 | Derivative | Performance Share Units | 2022-02-01 | A | A | 21,238 | $0.00 | 21,238 | D | — · — to — | 21,238 Performance Share Units | (F8) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,238 shares will be issued. The actual number of shares to be issued could range from a low of 4,248 at minimum performance to a high of 42,476 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F4) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F6) Vests on August 2, 2024. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-02-01 | A | A | 145,852 | $103.59 | 145,852 | D | $103.59 · 2023-02-01 to 2032-02-01 | 145,852 Ordinary Shares | (F7) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 6 | Derivative | Performance Share Units | 2022-02-01 | A | A | 15,591 | $0.00 | 15,591 | D | — · — to — | 15,591 Performance Share Units | (F5) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,591 shares will be issued. The actual number of shares to be issued could range from a low of 3,118 at minimum performance to a high of 31,182 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F4) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F6) Vests on August 2, 2024. |